Next Article in Journal
Bronchoalveolar Lavage Fluid-Isolated Biomarkers for the Diagnostic and Prognostic Assessment of Lung Cancer
Next Article in Special Issue
Pulmonary Artery Systolic Pressure and Cava Vein Status in Acute Heart Failure with Preserved Ejection Fraction: Clinical and Prognostic Implications
Previous Article in Journal
Deep Learning Approach in Image Diagnosis of Pseudomonas Keratitis
 
 
Article
Peer-Review Record

Left Ventricle Wall Motion Analysis with Real-Time MRI Feature Tracking in Heart Failure Patients: A Pilot Study

Diagnostics 2022, 12(12), 2946; https://doi.org/10.3390/diagnostics12122946
by Yu (Yulee) Li 1,2,*, Jason Craft 1, Yang (Josh) Cheng 1, Kathleen Gliganic 1, William Schapiro 1 and Jie (Jane) Cao 1,3
Reviewer 1: Anonymous
Reviewer 2:
Diagnostics 2022, 12(12), 2946; https://doi.org/10.3390/diagnostics12122946
Submission received: 2 October 2022 / Revised: 12 November 2022 / Accepted: 24 November 2022 / Published: 25 November 2022
(This article belongs to the Special Issue Advances and Challenges in Diagnosis and Management of Heart Failure)

Round 1

Reviewer 1 Report

In manuscript titled “Quantitative Assessment of Left Ventricle Wall Motion with Real-time MRI Feature Tracking in Heart Failure Patients”, the authors aim to validate a new cardiac MRI index, matching LV wall motion analysis in combination with volumetric measurement. 

The manuscript il well written and conclusions are potentially interesting in the field, moreover I have some comments:

1) the main limitation of this study is the small number of patients involved, nevertheless the results are interesting. I think authors should rephrase the title as follow: “Quantitative Assessment of Left Ventricle Wall Motion with Real-time MRI Feature Tracking in Heart Failure: a pilot study”.

2) author conclude that real-time MRI provide a cardiac MRI index, complementary to EF, for quantitative assessment of ventricular function. This improved HF evaluation, helping in differentiate HFpEF patients from healthy subjects. Could authors briefly explain what is the clinical application of this finding in the real life? i.e. reduction of hospitalizations? reduction of hectare costs? 

3) do the patients enrolled signed informed consent?

4) could the method presented reduce hospitalizations? I find this could be a pivotal result, also considering the high costs of HF hospitalization, particularly in aged patients. Please, briefly discuss this point also mentioning the following paper “Tersalvi G et al. Acute heart failure in elderly patients: a review of invasive and non-invasive management. J Geriatr Cardiol. 2021 Jul 28;18(7):560-576. doi: 10.11909/j.issn.1671-5411.2021.07.004.”

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

All measurements described are semiquantitative. Real-time measurements cannot be taken as relevant without an ECG signal. The measurement errors increases with the calculation of the indices.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

I appreciate authors efforts in revise the manuscript that results improved.

Reviewer 2 Report

This manuscript is tasked with increasing the importance and role of MRI techniques in the diagnosis and differentiation of patients with different categories of heart failure; for a group of patients in whom echocardiography for some reason it is not possible to do. Since Doppler echocardiography is the gold standard esspecially for the patients with HFpEF and HFmEF, it would be of interest to compare the hemodynamic and mechanic LV indices of both imaging techniques, in order to define more preciselly the diagnostic algorithms.

Back to TopTop